InvestorsHub Logo
icon url

maumar

12/12/22 4:03 PM

#7302 RE: Fred Kadiddlehopper #7300

One potential positive I see: Amgen may be able to expedite development of SC Tepezza and commercialize it more rapidly especially in the row, but I have no idea how interested they are in the SC formulation.